Emerging oral immunomodulating agents - focus on teriflunomide for the treatment of multiple sclerosis
{{output}}
Treatment for multiple sclerosis (MS), a chronic disease of the central nervous system, has historically relied exclusively on the use of injectable therapies. As the disease requires lifelong therapy, the development of oral therapies that are safe and effect... ...
